Camurus (SE)
Camurus AB is a Swedish research-based pharmaceutical company specializing in the development and commercialization of long-acting medicines for serious and chronic conditions. The company utilizes its proprietary FluidCrystal delivery technology to convert active pharmaceutical ingredients into long-acting subcutaneous depot formulations. Its core commercial product, Buvidal, is a long-acting buprenorphine depot treatment for opioid dependence, marketed globally under license agreements and direct commercial teams. Additional pipeline programs target central nervous system disorders, rare endocrine diseases, and oncology indications. Principal revenue drivers consist of direct pharmaceutical product sales, licensing royalties, milestone payments, and contract manufacturing agreements with commercial partners. Camurus holds a strong market position within long-acting addiction therapy across Europe and Australia. Headquartered in Lund, Sweden, the company's common shares are publicly listed and traded on Nasdaq Stockholm under the ticker CAMX.
37 of the funds FundTelligence covers report a position in Camurus (SE).
- Sector
- Health Care
- Country
- Sweden
- Funds holding it
- 37
- Exposure themes
- Addiction, Mental Health, Psychiatry
Funds holding Camurus (SE)
- Fondita Nordic Small Cap — Fondita · 3.9 % (largest positions only, October 2026)
- HealthInvest Small & Mid Cap Healthcare — HealthInvest · 3.9 % (partially disclosed portfolio, September 2026)
- Lannebo Sweden Micro Cap — Lannebo · 2.39 % (full portfolio disclosed, June 2026)
- PriorNilsson Småbolag — PriorNilsson · 1.87 % (full portfolio disclosed, June 2026)
- Aktiespararna Småbolag Edge — Cicero Fonder · 1.68 % (full portfolio disclosed, June 2026)
- Schroder ISF Nordic Smaller Companies — Schroders · 1.66 % (full portfolio disclosed, June 2026)
- HealthInvest Sustainable Healthcare — HealthInvest · 1.4 % (partially disclosed portfolio, September 2026)
- Nordnet Småbolag Sverige Index — Nordnet · 1.39 % (partially disclosed portfolio, October 2026)
Showing the 8 largest of 37 funds holding it.